CGRP antagonist compounds
US12227521B2 · kind B2 · utility
0Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2020 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Apr 6, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of Formula (1a): and salts thereof, wherein W, Z, L, R1 and R2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with CGRP receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.